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Background: Kinetic modeling of brain glucose metabolism in small rodents from positron emission tomography
(PET) data using 2-deoxy-2-[18 F]fluoro-D-glucose (FDG) has been highly inconsistent, due to different modeling
parameter settings and underestimation of the impact of methodological flaws in experimentation. This article aims
to contribute toward improved experimental standards. As solutions for arterial input function (IF) acquisition of
satisfactory quality are becoming available for small rodents, reliable two-tissue compartment modeling and the
determination of transport and phosphorylation rate constants of FDG in rodent brain are within reach.
Methods: Data from mouse brain FDG PET with IFs determined with a coincidence counter on an arterio-venous
shunt were analyzed with the two-tissue compartment model. We assessed the influence of several factors on the
modeling results: the value for the fractional blood volume in tissue, precision of timing and calibration, smoothing
of data, correction for blood cell uptake of FDG, and protocol for FDG administration. Kinetic modeling with
experimental and simulated data was performed under systematic variation of these parameters.
Results: Blood volume fitting was unreliable and affected the estimation of rate constants. Even small sample
timing errors of a few seconds lead to significant deviations of the fit parameters. Data smoothing did not increase
model fit precision. Accurate correction for the kinetics of blood cell uptake of FDG rather than constant scaling of
the blood time-activity curve is mandatory for kinetic modeling. FDG infusion over 4 to 5 min instead of bolus
injection revealed well-defined experimental input functions and allowed for longer blood sampling intervals at
similar fit precisions in simulations.
Conclusions: FDG infusion over a few minutes instead of bolus injection allows for longer blood sampling intervals
in kinetic modeling with the two-tissue compartment model at a similar precision of fit parameters. The fractional
blood volume in the tissue of interest should be entered as a fixed value and kinetics of blood cell uptake of FDG
should be included in the model. Data smoothing does not improve the results, and timing errors should be
avoided by precise temporal matching of blood and tissue time-activity curves and by replacing manual with
automated blood sampling.
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The need for reliable quantification in positron emission
tomography (PET) studies is self-evident: Data from dif-
ferent laboratories and from different subjects can be
compared meaningfully only if the same numbers always
mean the same thing. Clinical diagnostics and ethical is-
sues like the use of the smallest possible number of
laboratory animals depend on this. It is undesirable to
acquire control group data every time a new condition
or disease model is investigated. We have commented
on the impact of inherent variability and experimental
parameters on the reliability of small animal PET data in
general [1], here we discuss more specific issues. The
most commonly used tracer in PET is 2-deoxy-2-[18 F]
fluoro-D-glucose (FDG). The simplest way to compare
FDG datasets is by pseudo-quantification with standard
uptake values (SUV). It has been argued that this ap-
proach might be both unreliable and uninformative [2].
Kinetic modeling represents a more complicated but
preferable way of quantification. It yields kinetic infor-
mation on the mechanisms underlying the tissue uptake
of FDG. For the quantitative evaluation of FDG uptake
into the target tissue, kinetic modeling takes into account
the plasma FDG activity-time profile rather than the
applied FDG dose as used for SUV. Results are, therefore,
exclusively dependent on the uptake kinetics in the
studied tissue and are not affected by inter- and intra-
individual differences in systemic FDG disposition. The
standard model of brain FDG uptake is the two-tissue
compartment model, initially introduced as the autoradio-
graphic method [3]. It requires a time-activity curve
(TAC) from the tissue of interest and the arterial plasma
time-activity curve, the so-called input function (IF), to
derive single rate constants describing reversible transport
across the blood–brain barrier (K1 and k2) and phosphor-
ylation of FDG (k3) as well as hydrolysis of FDG-6-phos-
phate back to FDG (k4) [4]. The uptake rate constant of
FDG (KFDG) can subsequently be calculated from the rate
constants K1 to k3, as shown in Equation 1:
KFDG ¼ K1  k3k2 þ k3 ð1Þ
The cerebral glucose metabolic rate (CMRglc) is esti-
mated by dividing KFDG by the lumped constant (LC),
which corrects for the differences in the kinetics of FDG
and glucose regarding their transport and phosphoryl-
ation, and multiplication by the arterial plasma glucose
concentration (Gp), as shown in Equation 2 [5]:
CMRglc ¼ KFDG  1LC Gp ð2Þ
Uncertainty about the absolute values of the individual
rate constants from non-linear regression analysis withthe two-tissue compartment model has relatively little
effect on the calculated hybrid rate constant KFDG and fi-
nally CMRglc [6]. To accurately determine the single rate
constants, the following considerations need to be taken
into account. (1) Both IF and TAC need to be recorded
with short time intervals to cover rapid changes in activity
in blood and tissue of interest. In particular, the IF after a
bolus intravenous injection is characterized by rapid
changes at the start of the experiment. High-frequency
sampling of the IF has been challenging in rodents until
recently but is now becoming state of the art [7,8]. How-
ever, non-homogenous FDG distribution in the blood pool
during the first 30 s after a rapid injection can still lead to
erroneous results as blood radioactivity is, in general, not
determined directly in the tissue of interest [9]. Aside
from a high sampling frequency, the exact temporal match
of IF and TAC starting times is indispensable. (2) If radio-
activity is measured in whole blood, the IF needs to be
corrected for the hematocrit and the uptake kinetics of
FDG into red blood cells [10]. (3) Measured tissue radio-
activity requires the subtraction of the radioactivity in the
blood vessels of the respective tissue [11,12]. While blood
radioactivity is experimentally accessible, the exact frac-
tional volume of blood in the tissue of interest (vb) is
generally unknown. We consider these points as the major
reasons for the large variability in the data reported on
FDG kinetic modeling in rodent brain. Table 1 shows
some of the recently published results from FDG studies,
including claims that CMRglc under isoflurane is at levels
indicative of isoelectricity, i.e., a state without electric
neuronal signaling [13].
We have recently introduced an FDG infusion proto-
col for kinetic modeling in mice [7]. The purpose of
administering FDG over several minutes by a constant
infusion rate rather than by a rapid bolus was to over-
come the problem of inhomogeneous distribution in the
blood pool after rapid injection and to allow for longer
time intervals in the recording of radioactivity in blood
and tissue of interest. In this recent study, we made an
assumption for vb based on computed tomography mea-
surements [16]. Here, we address the question whether vb
can be reliably fitted from the IF, TAC, and blood time-
activity curve in mouse brain FDG kinetic modeling under
the applied experimental conditions. In parallel, we in-
vestigate the influence of data smoothing and time de-
lays between IF and TAC. In a next step, we assess the
influence of different IF corrections for FDG uptake into
blood cells. Finally, we evaluate by simulations whether
our infusion protocol indeed tolerates lower sampling
frequency of blood than bolus injection. This could be
of advantage for manual blood sampling or the gener-
ation of image-derived IFs, in particular in longitudinal
studies where shunt surgery for high-frequency blood
sampling is not feasible. Based on our findings, we
Table 1 Literature results of two-tissue compartmental FDG kinetic modeling in small rodents





Millet et al. [12] 0.14 ± 0.05 0.19 ± 0.25 0.07 ± 0.05 0.005 ± 0.004 0.044 ± 0.013 -a 90.3 ± 27.6 Urethane 0.6 R
Wu et al. [14] 0.10 ± 0.03 0.21 ± 0.10 0.05 ± 0.02 0.015 ± 0.006 0.019 ± 0.005 0 21.5 ± 4.3 Isoflurane 0.625 M
Yu et al. [15] 0.22 ± 0.05 0.48 ± 0.09 0.06 ± 0.02 0.025 ± 0.010 0.024 ± 0.007 0 40.6 ± 13.3 Isoflurane 0.6 M
Mizuma et al. [13] 0.20 ± 0.02 0.39 ± 0.05 0.14 ± 0.02 0.015 ± 0.002 0.053 ± 0.013 0 39 ± 3 Awake 0.625 M
Mizuma et al. [13] 0.156 ± 0.009 0.329 ± 0.005 0.032 ± 0.006 0.009 ± 0.004 0.014 ± 0.004 0 13 ± 4 Isoflurane 0.625 M
Alf et al. [7] 0.27 ± 0.09 0.57 ± 0.10 0.08 ± 0.02 0.018 ± 0.004 0.035 ± 0.013 5.5 61 ± 11 Isoflurane 0.6 M
Units for K1 to k4 as in Figure 3, KFDG in [mL/min/cm
3] and CMRglc in [μmol/min/100 g].
avb included in the model. Sp, species; M, mouse; R, rat.
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modeling.
Methods
Data acquisition and kinetic modeling
We used experimental TACs and blood-activity curves
from a previous study [7] with C57BL/6 mice (n = 5) with
normal glycemia (plasma glucose 11.9 ± 4.0 mmol/L (6.7
to 16.9 mmol/L)) for our analysis. In brief, animals were
under isoflurane (1.5% to 2%) anesthesia, and body
temperature and respiratory frequency were controlled at
36°C to 37°C and approximately 90 cycles/min, respect-
ively. FDG (10 to 14 MBq) was administered intravenously
as a constant infusion over 4.0 to 5.3 min. Blood radio-
activity was recorded with a coincidence counter (Twilite,
Swisstrace GmbH, Zurich, Switzerland) on a shunt vol-
ume of approximately 60 μL with 1-s temporal resolution.
List mode data were acquired for 45 min on a GE
Healthcare/Sedecal (Madrid, Spain) eXplore VISTA PET/
CT scanner in parallel.
Calibration of the coincidence counter with respect to
the PET scanner was performed daily. A syringe con-
taining approximately 1 MBq/cm3 FDG solution was at-
tached to a catheter as used for the shunt [7], and FDG
solution was flushed through the catheter which was
guided through the coincidence counter. The syringe
and catheter were measured simultaneously with scan-
ner and coincidence counter, respectively. FDG radio-
activity (Bq/cm3) was calculated from the images of the
calibrated scanner and divided by the coincidence counts
per cubic centimeter from the blood counter. This ratio
was used to calculate blood radioactivity in the animal
experiments.
If not stated otherwise, plasma radioactivity, i.e., the IF
was calculated from the blood radioactivity with Equa-
tion 3 correcting for blood cell uptake kinetics in mouse
[14,15]. For comparison, IFs were in addition calculated
with Equation 4, which was determined for blood cell up-
take kinetics in rats [8]. Furthermore, we calculated IFs
from the experimental blood data by multiplication with
the constant factor 1.165, which is the equilibrium parti-
tion coefficient determined by Wu et al. [14] (Equation 3).Finally, we also used the whole blood radioactivity as IF.
The four functions of plasma to blood radioactivity
(Ap/Ab) are plotted against time in Figure 1A.
Ap
Ab
¼ 0:386 e−0:191t minð Þ þ 1:165 ð3Þ
Ap
Ab
¼ 0:51 e−0:1447t minð Þ þ 0:3 e−0:00206t minð Þ
þ 0:8 ð4Þ
Image data were reconstructed into 33 to 39 time
frames with the shortest frames (10 s) around the infu-
sion stop and longer frames toward the end of the scan
(maximal length 240 s) and analyzed with PMOD v3.4
(PMOD Technologies Inc., Zurich, Switzerland). TACs
were derived from the cortex and hypothalamus, re-
spectively, with anatomic templates of PMOD covering
the entire structures. Figure 1B shows experimental TACs
and IF of one representative experiment.
Two-tissue compartment kinetic modeling was per-
formed with PMOD. A Marquardt-Levenberg algorithm
was used for fitting until convergence to unique solu-
tions. The LC for CMRglc calculation was 0.6 and vb
5.5% if not stated otherwise [7,16]. χ2 was used as indica-








where n is the total number of observations (Oi) and Ei
is the expected value for Oi as calculated with the fit
function.
Influence of choice of fractional blood volume on fit
parameters
The effect of different assumptions for vb on the fitted
model parameters and χ2 for the cortex and hypothal-
amus was tested by systematically varying vb between 0
and 0.2 (i.e., 0% and 20% blood in tissue, in steps of
0.5%). Alternatively, vb was included as a variable param-
eter in the fit. In order to reduce the impact of noise in
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Figure 1 Functions to generate IFs from blood radioactivity and data of a representative experiment. (A) Exponential functions and
scaling factor to calculate plasma form blood radioactivity. If not stated otherwise, the exponential function described in Equation 3 (Wu et al.
[14], solid green line) was used in this study. For comparison, IFs were calculated with the bi-exponential function described for rats (Weber et al.
[8]; dashed magenta line) and with a constant scaling factor corresponding to the equilibrium partition coefficient of plasma to blood (Wu et al.
[14]; dashed orange line). Finally, whole blood was used as IF for comparison (constant factor 1; dashed-dotted brown line). (B) Representative
data of an experiment (scan number V1131). Blood time-activity curve (grey), IF as calculated with the function in green in (A) (Wu et al. [14];
Equation 3), TAC of the cortex (red circles), and the hypothalamus (blue squares). Arrow indicates infusion duration.
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robust locally weighted regression (LOWESS) smoothing
as implemented in MATLAB. Furthermore, to assess the
effects of limited degrees of freedom, every second data
point was deleted from the experimental TACs. Modeling
was then performed as described above with fixed or vari-
able vb for each of the five scans with the following five
combinations: unmodified experimental IF with unmodi-
fied TAC or with TAC after deletion of every second data
point or with smoothed TAC, as well as smoothed IF with
unmodified TAC or with smoothed TAC. To visualize the
effect of the chosen vb on CMRglc, CMRglc values were
normalized to the averaged CMRglc over all vb for each
scan (CMRglc at a particular vb/averaged value of all calcu-
lated CMRglc of this scan) and plotted against vb. For the
rate constants K1 to k4, average values from the five scans
were plotted against vb.
Influence of time delays between IF and TAC and of
miscalibration between scanner and coincidence counter
To estimate the effect of time delays between TAC and IF,
we shifted the experimental unmodified IF relative to the
experimental unmodified TAC within a window of −20 to
30 s and plotted χ2 of the model fits (with constant vb
0.055) against the timing error. To visualize the influence
on CMRglc and the single rate constants, the parameters
were normalized to the respective value at zero time delay
for each scan (e.g., CMRglc (delay i)/CMRglc (no delay)).
To simulate a minor miscalibration by 5% betweenscanner and coincidence counter, the TAC was multiplied
with 0.95 and 1.05, respectively. The resulting model fit
parameters were compared to correctly time-matched and
calibrated data fitting results.
Fit of the IFs and simulations of IFs of a bolus and two
infusion protocols
For further analysis and simulations, IFs were fit with
the Solver add-in in Excel 2010 (Microsoft Office) with
the tri-exponential functions shown in Equations 6 and
7 [17]
Cinf ¼ Aþ Bþ Zð Þ
 f a 1−e−αtð Þ þ f β 1−e−βt
 þ f z 1−e−ζt  
ð6Þ
Cdecr ¼ Aþ Bþ Zð Þðf a 1−e−αtið Þe−α t−tið Þ







where Cinf is the arterial plasma radioactivity during the
infusion and Cdecr the radioactivity after infusion stop
(ti). The time point of infusion stop, ti, was determined
from the curve maximum by visual inspection of the
peak area of the IF. The sum of A, B, and Z corresponds
to the extrapolated radioactivity in arterial plasma at
steady state (infinite infusion duration). The fractional
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Z and α, β, ζ, as shown in Equations 8, 9, and 10:
f a ¼
A








ζ Aα þ Bβ þ Zζ
  ð10Þ
Note that A, B, and Z are proportional to the infusion
rate. A, B, Z and α, β, ζ were fit from the experimental
IFs and kinetic analysis of the PET data was performed
as described above with the fitted IF function. Fit FDG
rate constants were compared to those with experimen-
tal IFs.
Simulation of TACs and FDG kinetic modeling with
different infusion protocols
IFs with bolus/infusion durations of 10 s (bolus), 300 s
(similar to our experimental infusion protocol), and
900 s (for comparison) were simulated from the fit pa-
rameters A, B, Z, α, β, ζ with Equations 6 and 7 after
adjusting A, B, and Z to the respective infusion rate (at
equal FDG dose as in the experiment). The correspond-
ing TACs were simulated with the PMOD software,
applying the FDG two-tissue compartment model and
K1, k2, k3, k4 from the fits with the experimental IFs and
TACs with vb 0.055. The number and minimal/maximal
lengths of time frames for the simulated TACs were
equal to the experimental data; however, shortest time
frames were grouped around the corresponding injec-
tion/infusion stop. Blood radioactivities required for the
correction with vb were simulated from the generated IF
according to Equation 3.
Once IFs and TACs were generated, Gaussian noise
was added with the Excel function NORMINV to the
simulated data. The standard deviation for noise gener-
ation of the IF consisted of a constant between 25 and
40 kBq/cm3 plus 4% to 6% of the simulated plasma con-
centration. For TAC simulations, a relative standard de-
viation was chosen for the Gaussian noise corresponding
to the simulated TAC value multiplied with 0.8 and di-
vided by the lengths of the time interval in seconds.
These standard deviations yielded similar noise levels as
observed for the experimental data. For each animal and
infusion protocol, one IF and ten TACs were generated
as described above, and kinetic modeling was performed
with these simulated, noise-containing IFs and TACs as
described above. Fit parameters were compared to the
experimental values, and mean values and standarddeviations of the fitted parameters were compared be-
tween the bolus and infusion protocols.
Finally, to investigate the influence of sampling fre-
quency on the fit parameters and fitting precision (par-
ameter standard deviations), IF sampling intervals were
prolonged from the experimental 1 s to 30 s and 60 s,
respectively, by deleting the data between these time
points from both the experimental and above simulated
noise-containing IFs. Kinetic modeling was performed
with the identical simulated noise-containing TACs as
used for the complete IF datasets.Statistical analysis
Data are presented as mean ± SD; error bars in figures
represent SD and are further specified in the figure leg-
ends and text. Fitted parameters with the simulated IFs
and TACs were compared by two-tailed homoscedastic t
test. The effects of data smoothing and miscalibration
were assessed with paired-sample t test, corrected for
multiple comparisons (Bonferroni). Significant differences
are indicated with an asterisk (*) for P < 0.05 and double
asterisk (**) for P < 0.01.Results
Fractional blood volume
To estimate vb from the experimental FDG data, two-
tissue compartment modeling was performed by vary-
ing vb as a fixed value and by including vb as a variable
fit parameter, respectively. Analysis was performed with
full experimental datasets of the five scans and with
smoothed data and reduced TACs, respectively, as de-
scribed under the ‘Methods’ section. Figure 2A shows
the average χ2 of the modeling for the cortex with the
five scans as a function of vb. Table 2 shows the vb
values resulting in lowest χ2 when varied between 0%
and 20% as well as the fit values of vb when included as
fit parameter. In summary, data smoothing or reduc-
tion in TAC data had no significant influence on vb
yielding the lowest χ2 or on the fitted value for vb.
Comparing the two brain regions, vb was significantly
higher in the hypothalamus than the cortex under
three of the four fitting conditions (see Table 2). How-
ever, the respective vb values in the hypothalamus were
unrealistically high [16].
As shown in Figure 2B, the average value of CMRglc var-
ied by ±10% when varying vb between 0% and 15%. Indi-
vidual values of CMRglc deviated from the mean by >20%
at very low or high values of vb as indicated by the error
bars in Figure 2B. Figure 3 shows the dependency of the
single rate constants on the chosen value for vb. All single
rate constants negatively correlated with vb. Changes of vb
by 0.5% resulted in differences of up to 15% in individual
rate constants.
Figure 2 Effect of fractional blood volume on modeling with
data from the cortex. (A) Effect on goodness of fit (χ2). Original
data were more sensitive to unrealistically high vb in the model. (B)
Averaged CMRglc was increased by about 10% when vb was
assumed to be zero. Thin lines are drawn one average standard
deviation of the experimental data (n = 5 animals) above and below
the average data curve.
Table 2 Fractional blood volume (vb, in %) as estimated with
Full TAC 50% TAC
Cortex Min. χ2 a 3.8 ± 4.0 4.6 ± 3.4
Model fitb 7.2 ± 4.0 9.7 ± 7.2
Hypothalamus Min. χ2 12.7 ± 2.7c Not fitted
Model fit 11.7 ± 1.1c
aMin. χ2, vb was varied manually to yield the best goodness of fit (minimal χ
2). bMod
to respective value for the cortex but unrealistically high.
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Figures 2B and 3 show the influence of data smoothing
on CMRglc and rate constants. Data smoothing did not
affect CMRglc significantly, but significant differences oc-
curred between estimates of all single rate constants
with the original TAC and their estimates achieved with
any combination of the smoothed data vectors (P < 0.05)
with only one exception (comparison K1 with smooth IF
versus original data, see Figure 3A). In general, data
smoothing leads to underestimation of K1 and k2 by 5%
and 4%, respectively, when both TAC and IF were
smoothed, and to overestimation by 5% to 15% when only
TAC or IF were smoothed.
Delay between IF and TAC, calibration errors
Figure 4 shows the influence of delays between TAC and
IFs on the fit parameters. Goodness of fit was best at
zero delay between TAC and IF. Timing errors affected
CMRglc and the single rate constants. As little as a 5-s
delay in either direction resulted in significant (P < 0.05)
over- or underestimation of CMRglc (Figure 4B). The
effect on CMRglc was brought about by changes in all
single rate constants. Figure 4C shows the single rate
constants normalized by their respective value at zero
timing error. Timing errors of 20 s resulted in parameter
estimate errors of up to 60%.
Table 3 shows the consequences of calibration errors be-
tween scanner and coincidence counter. Miscalibration of
5% resulted in significantly wrong estimates of K1 (−7 ± 3%
and +6 ± 4% for too low and too high scanner/coincidence
counter calibration factors, respectively) and CMRglc (−5 ±
2% and +6 ± 4%), without affecting the other rate con-
stants. Goodness of fit was decreased but not significantly.
Correction for FDG blood cell uptake
IFs were calculated from the experimental blood radio-
activity data by four methods, two exponential correc-
tion functions published for mice (Equation 3) and rats
(Equation 4), taking into account uptake kinetics into
blood cells, and by scaling the blood activity-time curve
by a constant plasma/whole blood partition coefficient
or using the blood curve as the IF. The resulting rate
constants of the five scans are shown in Figure 5. In gen-
eral, the two exponential functions for mice and ratsthe two-tissue compartment model
Smooth IF Smooth TAC Smooth IF and TAC
3.7 ± 3.9 7.8 ± 6.2 6.3 ± 1.9
3.7 ± 3.8 15.1 ± 7.1 6.3 ± 1.8
Not fitted Not fitted 11.1 ± 5.0
11.5 ± 4.1c
el fit, vb was included as model parameter to be fitted.
cSignificant difference
Figure 3 Effect of fractional blood volume on the single rate constants. K1 (A) and k2 (B) showed an almost linear relationship in the cortex,
while the pattern for k3 (C) and k4 (D) was more complex. Effects were independent of the brain region. Single asterisk (*) denotes the results
from model fits using smoothed data deviated significantly (P < 0.05) from those achieved with the full TAC. Error bars are omitted for
better readability.
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(Figure 5) and hypothalamus (not shown). Applying the
whole blood radioactivity-time curve as the IF resulted
in an overestimation of K1 in the cortex and hypothal-
amus between 46% and 106% as compared to the param-
eters calculated with the IF according to Equation 3. The
rate constants k2 in the cortex and hypothalamus were
between 9% and 51% higher with the whole blood IF. All
k3 values were lower with the whole blood IF; they resulted
to between 68% and 95% of the reference values. Finally,
KFDG in the cortex and hypothalamus calculated with the
whole blood IF was between 96% and 129% of the refer-
ence data. Constant scaling with the equilibrium partition
coefficient increased K1 but to a lower extent than applying
the whole blood curve. The k3 values were similar with the
whole blood IF or the scaled IF in both the cortex and
hypothalamus. Finally, scaling resulted in similar CMRglc
values as the correction according to Equation 3; values
were within 84% and 103% of the reference values in the
cortex and hypothalamus.Non-linear regression analysis of experimental IF and
simulations of IF and TAC
To simulate IFs for bolus and infusion protocols, the
experimental IFs were fitted with Equations 6 and 7.
Figure 6 shows the agreement between fit and experi-
mental IFs. Based on the fit parameters, we simulated
IFs for bolus FDG injection (injection over 10 s) and con-
stant infusions over 300 s (similar to the experimental in-
fusion protocols) and 900 s. In a next step, we added
Gaussian noise to the simulated IFs. The resulting IFs are
shown in Figure 6. To study the influence of sampling fre-
quency on FDG kinetic parameters, we reduced the IF
data to data points in 30- and 60-s intervals, respectively.
The same was done with the experimental IFs.
TACs for the cortex were generated with PMOD from
the simulated IFs (before noise was added) and the ex-
perimental rate constants. From each generated TAC,
ten variations were calculated by the addition of ran-
dom Gaussian noise as described under the ‘Methods’
section.
Figure 4 Effect of blood sample timing errors. (A) Goodness of
fit was best at no delay between IF and TAC but significantly
decreased within the investigated range of time delay. (B) CMRglc
was sensitive to timing errors. A delay of as little as 5 s in either
direction resulted in significant changes. (C) Timing errors led to
large deviations in all single rate constants. Average values with
standard deviations from five animals each.
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experimental and simulated infusion protocols
As shown in Figure 7, FDG rate constants of simulated
bolus and 300-s infusion protocol, both at 1-s blood
sampling intervals, were similar to the rate constants de-
termined with experimental IFs (1-s blood sampling
interval). We first investigated whether kinetic modeling
with the experimental IF including only data points at
every 30 and 60 s, respectively, resulted in similar results
as with the complete IF with sampling frequency of 1 s.
As shown in Figure 7 for the cortex, K1, k2, k3, and KFDG
were within 82% and 128% of the reference values in the
cortex and hypothalamus (not shown). We next investi-
gated the influence of blood sampling frequency with
the simulated data for the 10-s bolus administration. As
expected, the 30-s sampling interval resulted in an
underestimation of the peak radioactivity at the end of
the injection (not shown). The effect on the rate constants
was striking as shown in Figure 7. All rate constants with
30-s sampling intervals for the bolus administration were
significantly higher than the rate constants simulated with
the 10-s bolus protocol and 1-s sampling intervals (all
with P < 0.001 except of one k3 value). In contrast, sam-
pling frequency had only a minor effect on the fit parame-
ters in the case of the 300-s infusion simulations, despite
some significant differences between the fits with different
sampling intervals. Standard deviations of the fit parame-
ters with the 10-s bolus and 300-s infusion protocols at 1-
s sampling interval were not significantly different. Fitting
precision was thus not significantly better with one or the
other protocol.
We extended the infusion duration to 900 s in the
simulations to investigate whether rate constants can
still be determined at longer infusion durations or whether
precision decreases with infusion duration. Overall, rate
constants were similar to the experimental values when
sampling at 1-s intervals (in average ca. 10% lower). How-
ever, rate constants were on average up to 26% lower (k2
and k3) than the experimental parameters (significant for
most constants but not indicated as such in the figure for
clarity). Figure 8 gives an explanation why the infusion
duration cannot be prolonged without losing information
for the model fitting. We simulated scans with IFs for
bolus (10 s) and infusions of 300- and 900-s duration as
above (Figure 8A). Figure 8B,C,D zooms into the simu-
lated TAC regions that are most important for fitting K1
Table 3 Relative changes in model estimates due to calibration errors
Calibration error scanner/counter K1 k2 k3 k4 CMRglc χ
2
−5% −7 ± 3%* −1 ± 6% +1 ± 5% +4 ± 8% −5 ± 2%* + 9 ± 24%
+5% +6 ± 4%* +1 ± 6% 0 ± 6% +4 ± 12% +6 ± 4%* +10 ± 28%
After correction for multiple comparisons, only the differences in K1 and CMRglc were significant. *P < 0.05.
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from the experiments (dark lines) and then increased K1
by 10% (1.1 ×K1) and increased k2 at the same time to
match the newly generated TAC to the original TAC as
close as possible. The respective factor for k2 was 1.11.
The remaining difference between the two TACs is most
prominent around the infusion stop (arrow in Figure 8C).
This remaining difference is indispensable to distinguish
the effects of K1 and k2 on the TAC. As shown in the fig-
ure, the difference between the two TACs dissipates as the
infusion duration increases. This illustrates how informa-
tion is lost with prolongation of infusion and the influ-
ences of K1 and k2 start to be indistinguishable.
Discussion
Glucose uptake and metabolism and, therefore, FDG
kinetics depend on many physiological factors. Minor devi-




































IF exper, Wu et al., 1997
IF exper, Weber et al., 2002
IF exper, scaled 1.165
IF exper, whole blood
C
Figure 5 Influence of the correction for blood cell uptake on FDG kin
V1131 to V1136 are scan numbers. IFs were calculated according to Equation 3
exper, Weber et al. [8]; for rats), with a constant scaling factor (light brown; IF edifferences between the results from FDG PET studies
[1,18,19]. However, without kinetic modeling and resolution
of the single process rate constants of FDG and glucose in
the region of interest, it is impossible to conclude whether
such differences result from divergences in systemic FDG
disposition, inconsistent data analysis or, indeed, differences
in glucose transport and phosphorylation in the region of
interest. In this work, we applied two-tissue compartment
kinetic modeling to exclude the influence of systemic FDG
disposition on the results. We focused on the application
protocol and parameters that influence data analysis in
kinetic modeling once the experimental part is completed.
We show that several parameters and conditions which are
often not paid much attention for can strikingly affect the
modeling results and may lead to erroneous conclusions
when comparing experimental results.
We showed that omission of vb in the model equation





































etic modeling in mouse brain cortex. (A) K1, (B) k2, (C) k3, (D) KFDG.
(black bars; IF exper, Wu et al. [14]; for mice), Equation 4 (magenta; IF












































10 s bolus simulation
300 s infusion simulation
















































Residuals 300 s infusion
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F
Figure 6 Experimental, fit, and simulated IFs. (A to E) Experimental IF (black), tri-exponential fit according to Equations 6 and 7 (yellow),
simulation 10-s bolus injection (blue), simulation 300-s constant infusion (red), simulation 900-s constant infusion (green) for scans V1131 (A),
V1132 (B), V1134 (C), V1135 (D), and V1136 (E). (F) Residuals between experimental IF and fit function in black and between simulated IF
(300-s infusion) with and without noise in red (scan V1131). Arrows in (A) indicate the duration of the infusions.
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modeling results. Transport parameters were most sensi-
tive to such methodological flaws, but k3 and k4 were
also affected, and even the allegedly robust CMRglc was
subject to substantial changes. The sensitivity of the
transport parameters to vb and timing errors is a conse-
quence of the shape of the IF: Correct estimation of K1
and k2 relies on the early time points of the IF and TAC,where equilibration between blood plasma and the free
tissue pool occurs.
Our calculations suggest that it is desirable to fix vb
for model fitting rather than including it as a fit param-
eter, even with more than sufficient data points in IF
and TAC, as its inclusion in the model did not lead to
increased model precision or even an accurate fit of vb
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IF experimental, 60 s intervals
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Simulation 10 s bolus, 30 s intervals
Simulation 300 s infusion, 1 s intervals
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Simulation 300 s infusion, 60 s intervals
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Figure 7 (See legend on next page.)
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Figure 7 Fit parameters generated with experimental and simulated IFs and TACs. (A) K1, (B) k2, (C) k3, (D) KFDG. IF exper as in Figure 5
(black bars). Experimental IFs were reduced to data points every 30 s (dark grey) and 60 s (light grey), respectively, and experimental TACs were
fitted with the reduced IFs. Data were in addition calculated with the fitted IF and experimental TACs (yellow). Bolus injection over 10 s simulated
with 1-s (dark blue) and 30-s (light blue) sampling intervals. Simulated infusion protocols over 300 s with 1-s (red), 30-s (medium red), and 60-s
(light red) sampling intervals. Simulated infusion over 900 s with 1-s (dark green) and 30-s (light green) sampling intervals. Simulated data are
averages of fits with ten simulated TACs each, error bars indicate the standard deviations of the ten fits. All simulated IFs and TACs contained
Gaussian noise, except of the fit IF (yellow). Single and double asterisk (* and **) denote some significant differences to the respective rate
constants of the 300-s infusion protocol, 1-s sampling interval at P < 0.05 and P < 0.01, respectively. Note that most rate constants of the 900-s
infusion protocol, 30-s sampling interval, were significantly (P < 0.01) lower than the corresponding rate constants at 300-s infusion, 1-s sampling.
Not all single asterisk (*) and double asterisk (**) are indicated for clarity.
Figure 8 Loss of information by prolonging the infusion duration. (A) Simulated IFs, bolus 10 s (dark line) and infusions 300 (dotted line)
and 900 s (grey line). (B) Zoom into TAC generated with a typical set of rate constants K1 0.328 mL/min/cm
3
, k2 0.550 min
−1, k3 0.079 min
−1, k4 0
(dark line). An additional TAC was generated by increasing K1 by 10% (1.1 × K1). At the same time, k2 was also increased to match the original
TAC as close as possible. The respective factor for k2 was 1.11 (1.11 × k2). TACs with either increased K1 or k2 are shown in addition. The newly
generated TAC with 1.1 × K1 and 1.11 × k2 deviates from the original TAC around the infusion stop, i.e., around the peak of the IF. This difference
is indispensable to distinguish between the effects of K1 and k2 on the TAC and thus for kinetic modeling. (C) TACs generated with the same rate
constants as in (B) for the 300-s infusion and (D) for the 900-s infusion. The difference between the two TACs (indicated by an arrow in C)
reduces as infusion duration increases, explaining the improper fit parameters with the simulated 900-s infusion protocol at longer sampling
intervals. Note that (B) to (D) zoom into the TAC region of interest and the activity scale, therefore starts at 600 Bq/cm3.
Alf et al. EJNMMI Research 2013, 3:61 Page 12 of 14
http://www.ejnmmires.com/content/3/1/61
Alf et al. EJNMMI Research 2013, 3:61 Page 13 of 14
http://www.ejnmmires.com/content/3/1/61vb and the fit estimates obtained for vb are unlikely to
reflect the true physiological situation. Even the inclu-
sion of larger vessel structures such as the circle of
Willis in the hypothalamic region of interest would not
lead to a vb of approximately 12% as suggested by mod-
eling. We, therefore, recommend the use of literature
values, e.g., from Chugh et al. [16] for vb in the brain re-
gion under investigation. The situation may be different
for bolus administration of FDG. At the very start of the
scan, when the IF reaches its peak, tissue radioactivity is
still low and vb may be better accessible than with our
infusion protocol.
Data smoothing did not result in greater precision of
parameter estimates but affected estimates of single rate
constants significantly. Smoothing the TAC removed at
least some information related to vb: The best goodness
of fit was shifted away from that of the original data fit
along the vb axis. Interpolation without curve smoothing
may be the best option, if additional degrees of freedom
are required for robust modeling.
Delay between starting times of IF and TAC and tim-
ing errors for early blood samples are likely to be among
the major causes of variation in previous reports. With-
out automated sampling tools such as beta probes [20]
or coincidence counters operating on a shunt volume
[7,8], it is virtually impossible to get correctly timed
samples because of catheter dead volume and the time
needed for transfer between animal and measurement
device or for blood plasma separation. We, therefore,
recommend the substitution of manual sampling with
automated, high temporal resolution sampling and to
pay particular attention to synchronization of starting
time of IF and TAC.
As expected from the impulse response function, sys-
tematic errors resulting in the multiplication of the input
function by a constant factor, such as calibration errors,
can only be compensated by K1. Rate constants k2 to k4
are in the exponents of the response function, defining
the shape of the TAC [3], which is not affected by this
kind of error.
The method how the IF is derived from the experimen-
tal blood data affects the single rate constants and CMRglc.
Based on our results, kinetic modeling with whole blood
IF or a constant scaling factor is not recommended. Our
comparison of two similar correction functions suggests
that minor inter- and intra-individual differences in blood
cell uptake of FDG may affect the results of kinetic model-
ing. This should be taken into account, and individual
kinetics of blood cell uptake should be determined
when comparing FDG kinetics of a heterogeneous
group of animals.
Our well-defined experimental IFs support the notion
that infusion instead of bolus injection avoids unpredict-
able blood activities at the early time points due to non-instant distribution of the FDG in the central, that is,
the measurement and input compartment [9]. We con-
clude from our simulations that loss of information for
modeling is negligible at moderate infusion duration of
5 min as compared to bolus administration. Based on
our simulation, a 5-min infusion protocol allows for
longer intervals between blood samples than a bolus in-
jection. The infusion protocol could thus allow kinetic
modeling under conditions where a shunt surgery is not
advisable and alternative less invasive blood sampling
techniques are required, e.g., in longitudinal studies. We
have successfully applied the infusion protocol for FDG
kinetic modeling with image-derived IFs [7]. Here, we
demonstrate in addition that infusion duration cannot
be prolonged further without loss in information for kin-
etic modeling.
We may have missed a fast initial distribution phase in
the simulated IFs of the bolus injection. The simulated
IF of bolus V1132 resembled closest the general shape of
an FDG bolus IF [15]. Results of this dataset were in
agreement with those of the other simulations. For this
reason and because an additional peak of short duration
would add to the overestimation of K1 and possibly
other rate constants if sampling intervals are not short-
ened, we conclude that our interpretation of the simu-
lated data with the 30-s sampling intervals are correct.
There are two other pertinent issues in the quantifica-
tion of CMRglc which are not addressed in this work.
One of them is the LC, which corrects for differences in
the kinetics of FDG compared to glucose [5]. The LC
can be derived from kinetic modeling results [21], but it
does not influence the rate constants of FDG deter-
mined in this work (i.e., K1 to k4 and KFDG). The data in
Table 1 all use similar LCs and can, therefore, be dir-
ectly compared to each other. The second issue is the
inclusion of the parameter describing dephosphoryla-
tion, k4, in the model [4]. As the results for other pa-
rameters were not significantly affected by k4 (which
was close to zero), we decided to include it in the model
for the present study.
Conclusions
To increase the reliability of FDG PET data modeling
with the two-tissue compartment model, we recommend
FDG infusion over about 5 min; to include an appropri-
ate value for the fractional blood volume in the tissue of
interest as well as to correct the IF for blood cell uptake
kinetics. Data smoothing was demonstrated to be an in-
appropriate manipulation, prohibiting precise and accur-
ate modeling. We also show that delays of a few seconds
between the start and early sampling of IF and TAC can
lead to substantial misestimates. We hope that our find-
ings will contribute toward improved methodological
standards in FDG kinetic modeling.
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